Life Science Solutions
DDI (2',3'-Dideoxyinosine)
Marketed in North America under the trade name Videx, 2',3'-dideoxyinosine, or DDI, is frequently utilized in the treatment of the human immunodeficiency virus (HIV) and the related acquired immune deficiency syndrome (AIDS). The pharmaceutical is associated with potentially very serious side effects, however, and was originally only prescribed after AZT-based therapy began to lose its effectiveness.
このページはお住まいの地域ではご覧いただくことはできません。
